Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 1 for:    NCT01280123
Previous Study | Return to List | Next Study

Pioglitazone in Early Parkinson's Disease

This study has been completed.
Sponsor:
Collaborators:
Michael J. Fox Foundation for Parkinson's Research
Information provided by (Responsible Party):
University of Rochester
ClinicalTrials.gov Identifier:
NCT01280123
First received: December 3, 2010
Last updated: February 3, 2015
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2014
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)
No publications provided by University of Rochester

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):